Ledipasvir D tartrate is a salt form of the antiviral agent ledipasvir, a potent NS5A inhibitor used in the treatment of chronic hepatitis C virus infection. Analytical laboratories require high-quality… Read more
Ledipasvir D tartrate is a salt form of the antiviral agent ledipasvir, a potent NS5A inhibitor used in the treatment of chronic hepatitis C virus infection. Analytical laboratories require high-quality reference standards of this compound, including related impurities, metabolites, and degradation products, to ensure accurate identification and quantification during pharmaceutical quality control and method validation. The availability of these materials is essential for rigorous impurity profiling and regulatory compliance throughout the drug development lifecycle. Furthermore, stable isotope labelled compounds are utilized as internal standards in advanced bioanalytical assays, such as LC-MS/MS, to improve precision and overcome matrix effects when quantifying drug concentrations in biological samples. By providing these specific analytical tools, researchers can maintain the reliability and sensitivity needed for complex stability studies and pharmacokinetic evaluations of ledipasvir-based therapies.